Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bon Natural Life (BON) Cash & Current Investments (2020 - 2025)

Bon Natural Life (BON) has disclosed Cash & Current Investments for 5 consecutive years, with $80466.0 as the latest value for Q3 2024.

  • On a quarterly basis, Cash & Current Investments fell 91.97% to $80466.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $80466.0, a 91.97% decrease, with the full-year FY2024 number at $80466.0, down 91.97% from a year prior.
  • Cash & Current Investments was $80466.0 for Q3 2024 at Bon Natural Life, down from $1.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $2.9 million in Q3 2021 to a low of $53106.0 in Q3 2020.
  • A 5-year average of $1.2 million and a median of $1.0 million in 2023 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: surged 5368.06% in 2021, then crashed 91.97% in 2024.
  • Bon Natural Life's Cash & Current Investments stood at $53106.0 in 2020, then soared by 5368.06% to $2.9 million in 2021, then crashed by 36.61% to $1.8 million in 2022, then tumbled by 45.6% to $1.0 million in 2023, then plummeted by 91.97% to $80466.0 in 2024.
  • Per Business Quant, the three most recent readings for BON's Cash & Current Investments are $80466.0 (Q3 2024), $1.0 million (Q3 2023), and $1.8 million (Q3 2022).